Postoperative pathology revealed diffuse large B-cell lymphoma (DLBCL), with immunohistochemically related positive indicators, including CD20, CD79a, LCA, MUM-1, PAX5, C-MYC, BCL-2, and BCL-6, in all patients. Here, MYC is linked to diffuse large B-cell lymphoma.